Minimally invasive correction of stress urinary incontinence in women with pelvic floor dysfunction

Abstract

BACKGROUND: Pelvic floor dysfunction is widespread among young women. Stress urinary incontinence is a common manifestation of the dysfunction and, even in mild forms, affects the quality of life of patients. Much attention is focused on finding and improving minimally invasive methods for treating stress urinary incontinence in women of reproductive and perimenopausal age to prevent disease progression and improve quality of life.

AIM: The aim of this study was to evaluate the immediate and long-term results of paraurethral injections of a high-density hyaluronic biopolymer for the correction of stress urinary incontinence in women of reproductive and perimenopausal age.

MATERIALS AND METHODS: We examined 37 patients aged 44.6 ± 4.7 years with mild to moderate stress urinary incontinence combined with grade I to II genital prolapse. After general clinical and special studies (urination diaries, King’s and Pelvic Organ Prolapse / Urinary Incontinence Sexual Questionnaire, cough test, complex urodynamic study, ultrasound examination of the urethrovesical junction and pelvic floor ultrasound with compression elastography), paraurethral injection of 4.0 ml of the high-density hyaluronic biopolymer crosslinked with 1,4-butanediol diglycidyl ether was performed. The effectiveness of therapy was evaluated 1, 6 and 12 months after the procedure.

RESULTS: A negative cough test was detected after one, six and 12 months of follow-up in 96.9, 73.1 and 43.8 % of women, respectively; the absence of stress urinary incontinence episodes according to urination diaries was in 85.7, 61.3 and 35.0 % of patients, respectively. Gradual resorption of the drug was monitored over 12 months of observation. An ultrasound examination showed a decrease in urethral mobility one month after the procedure. According to the results of elastography before treatment, the average value of the strain ratio of paraurethral tissues was 0.50 (0.30–0.69) (p < 0.001), after one and six months — 0.88 (0.76–1.03) and 0.79 (0.66–1.07) (p < 0.001 and p = 0.005 respectively). Thus, the stiffness of the paraurethral tissues of the proximal posterior wall of the urethra increased within six months after the procedure. When observing women after 12 months, the stiffness values of the studied tissues decreased and approached the values before treatment. During the entire observation period, the patients noted a decrease in the degree of discomfort due to problems with urination according to the questionnaires.

CONCLUSIONS: The introduction of the high-density hyaluronic biopolymer helps to increase the stiffness of paraurethral tissues and improve the structural support of the urethra in patients with stress urinary incontinence. After the procedure, a 12-month follow-up revealed a decrease or absence of stress urinary incontinence episodes according to urination diaries and the preservation of the positive effect of treatment according to the results of the cough test. A gradual decrease in the effect of therapy is associated with biodegradation of the drug. This method of treating mild forms of stress urinary incontinence is effective for women of reproductive and perimenopausal age who do not plan surgical treatment, are interested in achieving a quick result of therapy and are informed that the effect decreases over time after the procedure.

Keywords

pelvic floor dysfunction / stress urinary incontinence / bulking agents / hyaluronic biopolymer

References

[1] Peinado-Molina RA, Hernández-Martínez A, Martínez-Vázquez S, et al. Pelvic floor dysfunction: prevalence and associated factors. BMC Public Health. 2023;23(1):2005. doi: 10.1186/S12889-023-16901-3

[2] Peinado-Molina R.A., Hernández-Martínez A., Martínez-Vázquez S., et al. Pelvic floor dysfunction: prevalence and associated factors // BMC Public Health. 2023. Vol. 23, N. 1. Р. 2005. doi: 10.1186/S12889-023-16901-3

[3] AlQuaiz AJM, Kazi A, AlYousefi N, et al. Urinary incontinence affects the quality of life and increases psychological distress and low self-esteem. Healthcare. 2023;11(12):1772. doi: 10.3390/HEALTHCARE11121772

[4] AlQuaiz AJ.M., Kazi A., AlYousefi N., et al. Urinary incontinence affects the quality of life and increases psychological distress and low self-esteem // Healthcare. 2023. Vol. 11, N. 12. Р. 1772. doi: 10.3390/HEALTHCARE11121772

[5] Xue K, Palmer MH, Zhou F. Prevalence and associated factors of urinary incontinence in women living in China: a literature review. BMC Urol. 2020;20(1):159. doi: 10.1186/S12894-020-00735-X

[6] Xue K., Palmer M.H., Zhou F. Prevalence and associated factors of urinary incontinence in women living in China: a literature review // BMC Urol. 2020. Vol. 20, № 1. Р. 159. doi: 10.1186/S12894-020-00735-X

[7] Alves JO, Da Luz ST, Brandão S, et al. Urinary incontinence in physically active young women: prevalence and related factors. Int J Sports Med. 2017;38(12):937–941. doi: 10.1055/S-0043-115736

[8] Alves J.O., Da Luz S.T., Brandão S., et al. Urinary incontinence in physically active young women: prevalence and related factors // Int J Sports Med. 2017. Vol. 38, N. 12. P. 937–941. doi: 10.1055/S-0043-115736

[9] Sazonova NA, Kiseleva MG, Gadzhieva ZK, et al. Urinary incontinence in women and its impact on quality of life. Urologiia. 2022;(2):136–139. EDN: DUSNHR doi: 10.18565/urology.2022.2.136-139

[10] Сазонова Н.А., Киселева М.Г., Гаджиева З.К., и др. Недержание мочи у женщин и его влияние на качество жизни // Урология. 2022. № 2. С. 136–139. EDN: DUSNHR doi: 10.18565/urology.2022.2.136-139

[11] Neymark AI, Razdorskaya MV. Nederzhanie mochi u zhenshchin. Moscow: GEOTAR-Media, 2013. EDN: VTMOHL

[12] Неймарк А.И., Раздорская М.В. Недержание мочи у женщин. Москва: ГЭОТАР-Медиа, 2013. EDN: VTMOHL

[13] Delancey JOL. Why do women have stress urinary incontinence? Neurourol Urodyn. 2010;29(Suppl 1):S13–S17. doi: 10.1002/NAU.20888

[14] Delancey J.O.L. Why do women have stress urinary incontinence? // Neurourol Urodyn. 2010. Vol. 29, Suppl 1. Р. S13–S17. doi: 10.1002/NAU.20888

[15] Serati M, Braga A, Salvatore S, et al. Up-to-date procedures in female stress urinary incontinence surgery: a concise review on bulking agents procedures. Medicina (Kaunas). 2022;58(6):776. doi: 10.3390/MEDICINA58060775

[16] Serati M., Braga A., Salvatore S., et al. Up-to-date procedures in female stress urinary incontinence surgery: a concise review on bulking agents procedures // Medicina (Kaunas). 2022. Vol. 58, N. 6. Р. 775. doi: 10.3390/MEDICINA58060775

[17] Serati M, Braga A, Caccia G, et al. TVT-O for treatment of pure urodynamic stress urinary incontinence: Efficacy and adverse effects at 13-years follow-up. Neurourol Urodyn. 2020;39(5):1423–1429. doi: 10.1002/NAU.24358

[18] Serati M., Braga A., Caccia G., et al. TVT-O for treatment of pure urodynamic stress urinary incontinence: Efficacy and adverse effects at 13-years follow-up // Neurourol Urodyn. 2020. Vol. 39, N. 5. P. 1423–1429. doi: 10.1002/NAU.24358

[19] Chapple C, Dmochowski R. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence. Res Rep Urol. 2019;11:299–310. doi: 10.2147/RRU.S220216

[20] Chapple C., Dmochowski R. Particulate versus non-particulate bulking agents in the treatment of stress urinary incontinence // Res Rep Urol. 2019. Vol. 11. P. 299–310. doi: 10.2147/RRU.S220216

[21] Kirchin V, Page T, Keegan PE, et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7(7). doi: 10.1002/14651858.CD003881.pub4

[22] Kirchin V., Page T., Keegan P.E., et al. Urethral injection therapy for urinary incontinence in women. // Cochrane Database Syst Rev. 2017. Vol. 7, N. 7. doi: 10.1002/14651858.CD003881.pub4

[23] Rusina EI, Zhevlakova MM. Bulking agents for minimally invasive correction of stress urinary incontinence in women. Journal of Obstetrics and Women’s Diseases. 2023;72(5):75–88. EDN: ZAANEL doi: 10.17816/JOWD501805

[24] Русина Е.И., Жевлакова М.М. Объемообразующие вещества при малоинвазивной коррекции стрессового недержания мочи у женщин // Журнал акушерства и женских болезней. 2021. Т. 72, № 4. С. 75–88. EDN: ZAANEL doi: 10.17816/JOWD501805

[25] Tsukanov AYu, Mirzakadiev AA, Dunkurs AV. The first experience of injecting of bulking agents in mild stress incontinence in reproductive age womens. Experimental and Сlinical Urology. 2020;12(2):158–163. EDN: DQTNIN doi: 10.29188/2222-8543-2020-12-2-158-163

[26] Цуканов А.Ю., Мирзакадиев А.А., Дункурс А.В. Первый опыт инъекционного введения объем-образующих веществ при стрессовом недержании мочи легкой степени у женщин репродуктивного возраста // Экспериментальная и клиническая урология. 2020. Т. 12, № 2. С. 158–163. EDN: DQTNIN doi: 10.29188/2222-8543-2020-12-2-158-163

[27] Tsukanov AYu, Mirzakadiev AA, Dunkurs AV. Bulking agents in case of treatment of female stress urinary incontinence. Urology Herald. 2020;8(2):99–106. EDN: BSFBIS doi: 10.21886/2308-6424-2020-8-2-99-106

[28] Цуканов А.Ю., Мирзакадиев А.А., Дункурс А.В. Объем-образующие вещества в лечении стрессового недержания мочи у женщин // Вестник урологии. 2020. Т. 8, № 2. C. 99–106. EDN: BSFBIS doi: 10.21886/2308-6424-2020-8-2-99-106

[29] Galeeva AG. Local change in skin metabolism with intradermal injection of unstabilized hyaluronic acid in an experiment: abstract of thesis [dissertation]. Ryazan; 2018. Available from: https://www.dissercat.com/content/lokalnye-izmeneniya-metabolizma-kozhi-pri-vnutridermalnom-vvedenii-nestabilizirovannoi-vysok EDN: XSNMCD

[30] Галеева А.Г. Локальное изменение метаболизма кожи при внутридермальном введении нестабилизированной гиалуроновой кислоты в эксперименте: автореф. дис. …канд. мед. наук. Рязань, 2018. Режим доступа: https://www.dissercat.com/content/lokalnye-izmeneniya-metabolizma-kozhi-pri-vnutridermalnom-vvedenii-nestabilizirovannoi-vysok. Дата обращения 13.12.2023. EDN: XSNMCD

[31] Fundarò SP, Salti G, Malgapo DMH, et al. The rheology and physicochemical characteristics of hyaluronic acid fillers: their clinical implications. Int J Mol Sci. 2022;23(18). doi: 10.3390/IJMS231810518

[32] Fundarò S.P., Salti G., Malgapo D.M.H., et al. The rheology and physicochemical characteristics of hyaluronic acid fillers: their clinical implications // Int J Mol Sci. 2022. Vol. 23, N. 18. doi: 10.3390/IJMS231810518

[33] Kan DV. Guide to obstetric and gynecological urology. Moscow: Medicine; 1986.

[34] Кан Д.В. Руководство по акушерской и гинекологической урологии. Москва: Медицина, 1986.

[35] Russian Society of Obstetricians and Gynecologists, All-Russian public organization “Russian Society of Urologists”. Prolapse of female genital organs. Clinical recommendations. 2021. Available from: https://cr.minzdrav.gov.ru/schema/647_1 (In Russ.)

[36] Российское общество акушеров-гинекологов, Общероссийская общественная организация «Российское общество урологов». Выпадение женских половых органов. Клинические рекомендации. 2021. Режим доступа: https://cr.minzdrav.gov.ru/schema/647_1. Дата обращения: 13.12.2023.

[37] Chechneva MA, Buyanova SN, Popov AA, et al. Ultrasound diagnosis of genital prolapse and urinary incontinence in women. Moscow: MEDpress-inform; 2016. (In Russ.)

[38] Чечнева М.А., Буянова С.Н., Попов А.А., и др. Ультразвуковая диагностика пролапса гениталий и недержания мочи у женщин. Москва: МЕДпресс-информ, 2016.

[39] Rusina EI, Zhevlakova MM, Shelayeva EV, et al. Possibilities of elastography in the diagnosis of stress urinary incontinence in women. Journal of Obstetrics and Women’s Diseases. 2023;72(5):75–88. EDN: GKSZLO doi: 10.17816/JOWD501805

[40] Русина Е.И., Жевлакова М.М., Шелаева Е.В. и др. Возможности эластографии в диагностике стрессового недержания мочи у женщин // Журнал акушерства и женских болезней. 2023. Т. 72, № 5. С. 75–88. EDN: GKSZLO doi: 10.17816/JOWD501805

[41] Mazloomdoost D, Westermann LB, Mutema G, et al. Histologic anatomy of the anterior vagina and urethra. Female Pelvic Med Reconstr Surg. 2017;23(5):329–335. doi: 10.1097/SPV.0000000000000387

[42] Mazloomdoost D., Westermann L.B., Mutema G., et al. Histologic anatomy of the anterior vagina and urethra // Female Pelvic Med Reconstr Surg. 2017. Vol. 23, N. 5. P. 329–335. doi: 10.1097/SPV.0000000000000387

[43] Hamner JJ, Carrick KS, Ramirez DMO, et al. Gross and histologic relationships of the retropubic urethra to lateral pelvic sidewall and anterior vaginal wall in female cadavers: clinical applications to retropubic surgery. Am J Obstet Gynecol. 2018;219(6):597.e1–597.e8. doi: 10.1016/J.AJOG.2018.09.037

[44] Hamner J.J., Carrick K.S., Ramirez D.M.O., et al. Gross and histologic relationships of the retropubic urethra to lateral pelvic sidewall and anterior vaginal wall in female cadavers: clinical applications to retropubic surgery // Am J Obstet Gynecol. 2018. Vol. 219, N. 6. P. 597.e1–597.e8. doi: 10.1016/J.AJOG.2018.09.037

[45] Rusina EI, Zhevlakova MM. Remote pelvic floor muscle training in the treatment of stress urinary incontinence in women. Journal of Obstetrics and Women’s Diseases. 2023;72(3):105–115. EDN: ESHEYN doi: 10.17816/JOWD430311

[46] Русина Е.И., Жевлакова М.М. Дистанционные тренировки мышц тазового дна в лечении стрессового недержания мочи у женщин // Журнал акушерства и женских болезней. 2023. Т. 72, № 3. С. 105–115. EDN: ESHEYN doi: 10.17816/JOWD430311

[47] Russian Society of Urologists. Urinary incontinence. Clinical recommendations. 2020. Available from: http://disuria.ru/_ld/7/730_kr20N39p3R32mz.pdf (In Russ.)

[48] Российское общество урологов. Недержание мочи. Клинические рекомендации. 2020. Режим доступа: http://disuria.ru/_ld/7/730_kr20N39p3R32mz.pdf. Дата обращения: 13.12.2023.

[49] Pivazyan L, Kasyan G, Grigoryan B, et al. Effectiveness and safety of bulking agents versus surgical methods in women with stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J. 2022;33(4):777–787. doi: 10.1007/S00192-021-04937-1

[50] Pivazyan L., Kasyan G., Grigoryan B., et al. Effectiveness and safety of bulking agents versus surgical methods in women with stress urinary incontinence: a systematic review and meta-analysis // Int Urogynecol J. 2022. Vol. 33, N. 4. P. 777–787. doi: 10.1007/S00192-021-04937-1

[51] Capobianco G, Saderi L, Dessole F, et al. Efficacy and effectiveness of bulking agents in the treatment of stress and mixed urinary incontinence: a systematic review and meta-analysis. Maturitas. 2020;133:13–31. doi: 10.1016/j.maturitas.2019.12.007

[52] Capobianco G., Saderi L., Dessole F., et al. Efficacy and effectiveness of bulking agents in the treatment of stress and mixed urinary incontinence: a systematic review and meta-analysis // Maturitas. 2020. Vol. 133. P. 13–31. doi: 10.1016/j.maturitas.2019.12.007

[53] Bezhenar VF, Arakelyan B V., Krutova VA, et al. Urethral bulking agents in the treatment of stress urinary incontinence. Kuban Scientific Medical Bulletin. 2019;26(4):84–93. (In Russ.) EDN: FCEMLZ doi: 10.25207/1608-6228-2019-26-4-84-93

[54] Беженарь В.Ф., Аракелян Б.В., Крутова В.А., и др. Применение объемообразующих веществ в лечении стрессового недержания мочи // Кубанский научный медицинский вестник. 2019. Т. 26, № 4. С. 84–93. EDN: FCEMLZ doi: 10.25207/1608-6228-2019-26-4-84-93

[55] Hoe V, Haller B, Yao HH, et al. Urethral bulking agents for the treatment of stress urinary incontinence in women: a systematic review. Neurourol Urodyn. 2021;40(6):1349–1388. doi: 10.1002/NAU.24696

[56] Hoe V., Haller B., Yao H.H., et al. Urethral bulking agents for the treatment of stress urinary incontinence in women: a systematic review // Neurourol Urodyn. 2021. Vol. 40, N. 6. P. 1349–1388. doi: 10.1002/NAU.24696

[57] Itkonen Freitas AM, Mentula M, Rahkola-Soisalo P, et al. Tension-free vaginal tape surgery versus polyacrylamide hydrogel injection for primary stress urinary incontinence: a randomized clinical trial. J Urol. 2020;203(2):372–378. doi: 10.1097/JU.0000000000000517

[58] Itkonen Freitas A.M., Mentula M., Rahkola-Soisalo P., et al. Tension-free vaginal tape surgery versus polyacrylamide hydrogel injection for primary stress urinary incontinence: a randomized clinical trial // J Urol. 2020. Vol. 203, N. 2. P. 372–378. doi: 10.1097/JU.0000000000000517

[59] Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–213. doi: 10.1097/01.SLA.0000133083.54934.AE

[60] Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey // Ann Surg. 2004. Vol. 240, N. 2. P. 205–213. doi: 10.1097/01.SLA.0000133083.54934.AE

[61] Chapple CR, Haab F, Cervigni M, et al. An open, multicentre study of NASHA/Dx gel (ZuidexTM) for the treatment of stress urinary incontinence. Eur Urol. 2005;48(3):488–494. doi: 10.1016/j.eururo.2005.05.007

[62] Chapple C.R., Haab F., Cervigni M., et al. An open, multicentre study of NASHA/Dx gel (ZuidexTM) for the treatment of stress urinary incontinence // Eur Urol. 2005. Vol. 48, N. 3. P. 488–494. doi: 10.1016/j.eururo.2005.05.007

[63] Apolikhina IA, Saidova AS, Makhmedzhanova FN. Use of volume-forming drugs to treat female stress urinary incontinence. Obstetrics and Gynecology. 2011;(7–1):21–24. EDN: PFTVBX

[64] Аполихина И.А., Саидова А.С. Махмеджанова Ф.Н. Применение объемообразующих средств в лечении стрессового недержания мочи у женщин // Акушерство и гинекология. 2011. Т. 7–1. С. 21–24. EDN: PFTVBX

[65] Lightner D, Rovner E, Corcos J, et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of zuidex via the implacer versus proximal urethral injection of contigen cystoscopically. Urology. 2009;74(4):771–775. doi: 10.1016/j.urology.2009.05.034

[66] Lightner D., Rovner E., Corcos J., et al. Randomized controlled multisite trial of injected bulking agents for women with intrinsic sphincter deficiency: mid-urethral injection of zuidex via the implacer versus proximal urethral injection of contigen cystoscopically // Urology. 2009. Vol. 74, N. 4. P. 771–775. doi: 10.1016/j.urology.2009.05.034

[67] Harding C.K., Lapitan M.C., Arlandis S., et al. EAU guidelines on management of non-neurogenic female lower urinary tract symptoms. European Association of Urology; 2023. Available from: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-neurogenic-Female-LUTS-2023.pdf

[68] Harding C.K., Lapitan M.C., Arlandis S., et al. EAU guidelines on management of non-neurogenic female lower urinary tract symptoms. European Association of Urology, 2023. Режим доступа: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-neurogenic-Female-LUTS-2023.pdf. Дата обращения: 13.12.2023

[69] Elzayat EA, Karsenty G, Bismar TA, et al. Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(2):247–252. doi: 10.1007/s00192-007-0414-9

[70] Elzayat E.A., Karsenty G., Bismar T.A., et al. Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats // Int Urogynecol J Pelvic Floor Dysfunct. 2008. Vol. 19, N. 2. P. 247–252. doi: 10.1007/s00192-007-0414-9

[71] De Boulle K, Glogau R, Kono T, et al. A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers. Dermatol Surg. 2013;39(12):1758–1766. doi: 10.1111/DSU.12301

[72] De Boulle K., Glogau R., Kono T., et al. A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers // Dermatol Surg. 2013. Vol. 39, N. 12. P. 1758–1766. doi: 10.1111/DSU.12301

[73] Watad A, Quaresma M, Bragazzi NL, et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA)/Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry. Clin Rheumatol. 2018;37(2):483–493. doi: 10.1007/s10067-017-3748-9

[74] Watad A., Quaresma M., Bragazzi N.L., et al. The autoimmune/inflammatory syndrome induced by adjuvants (ASIA) / Shoenfeld’s syndrome: descriptive analysis of 300 patients from the international ASIA syndrome registry // Clin Rheumatol. 2018. Vol. 37, N. 2. P. 483–493. doi: 10.1007/s10067-017-3748-9

[75] Zakirova GS, Gubanova EI, Gladko VV, et al. A randomized study of the safety and effectiveness of products based on stabilized hyaluronic acid for the correction of involutional changes in face and neck. Russian Journal of Skin and Venereal Diseases. 2018;21(1):53–60. EDN: XTCGRF doi: 10.18821/1560-9588-2018-21-1-51-53-60

[76] Закирова Г.Ш., Губанова Е.И., Гладько В.В., и др. Рандомизированное исследование безопасности и эффективности препаратов на основе стабилизированной гиалуроновой кислоты для коррекции инволюционных изменений кожи лица и шеи // Российский журнал кожных и венерических болезней. 2018. Т. 21, № 1. С. 53–60. EDN: XTCGRF doi: 10.18821/1560-9588-2018-21-1-51-53-60

[77] Steele AC, Kohli N, Karram MM. Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstetrics and gynecology. 2000;95(3):327–331. doi: 10.1016/S0029-7844(99)00568-2

[78] Steele A.C., Kohli N., Karram M.M. Periurethral collagen injection for stress incontinence with and without urethral hypermobility // Obstet Gynecol. 2000. Vol. 95, N. 3. P. 327–331. doi: 10.1016/S0029-7844(99)00568-2

[79] Kuhn A, Stadlmayr W, Lengsfeld D, et al. Where should bulking agents for female urodynamic stress incontinence be injected? Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(6):817–821. doi: 10.1007/S00192-007-0535-1

[80] Kuhn A., Stadlmayr W., Lengsfeld D., et al. Where should bulking agents for female urodynamic stress incontinence be injected? // Int Urogynecol J Pelvic Floor Dysfunct. 2008. Vol. 19, N. 6. P. 817–821. doi: 10.1007/S00192-007-0535-1

[81] Yao F, Laudano MA, Seklehner S, et al. Image-based simulation of urethral distensibility and flow resistance as a function of pelvic floor anatomy. Neurourol Urodyn. 2015;34(7):664–668. doi: 10.1002/NAU.22624

[82] Yao F., Laudano M.A., Seklehner S., et al. Image-based simulation of urethral distensibility and flow resistance as a function of pelvic floor anatomy // Neurourol Urodyn. 2015. Vol. 34, N. 7. P. 664–668. doi: 10.1002/NAU.22624

[83] Tanridan Okcu N, Vuruskan E, Gorgulu FF. Use of shear wave elastography to evaluate stress urinary incontinence in women. J Coll Physicians Surg Pak. 2021;31(10):1196–1201. doi: 10.29271/jcpsp.2021.10.1196

[84] Tanrıdan Okcu N., Vuruskan E., Gorgulu FF. Use of shear wave elastography to evaluate stress urinary incontinence in women // J Coll Physicians Surg Pak. 2021. Vol. 31, N. 10. P. 1196–1201. doi: 10.29271/jcpsp.2021.10.1196

[85] Urdiales-Gálvez F, Braz A, Cavallini M. Facial rejuvenation with the new hybrid filler HArmonyCaTM: Clinical and aesthetic outcomes assessed by 2D and 3D photographs, ultrasound, and elastography. J Cosmet Dermatol. 2023;22(8):2186–2197. doi: 10.1111/JOCD.15706

[86] Urdiales-Gálvez F., Braz A., Cavallini M. Facial rejuvenation with the new hybrid filler HArmonyCaTM: Clinical and aesthetic outcomes assessed by 2D and 3D photographs, ultrasound, and elastography // J Cosmet Dermatol. 2023. Vol. 22, N. 8. P. 2186–2197. doi: 10.1111/JOCD.15706

[87] Ageeli W, Zhang X, Ogbonnaya CN, et al. Characterisation of collagen re-modelling in localised prostate cancer using second-generation harmonic imaging and transrectal ultrasound shear wave elastography. Cancers. 2021;13(21):5553. doi: 10.3390/CANCERS13215553

[88] Ageeli W., Zhang X., Ogbonnaya C.N., et al. Characterisation of collagen re-modelling in localised prostate cancer using second-generation harmonic imaging and transrectal ultrasound shear wave elastography // Cancers (Basel). 2021. Vol. 13, N. 21. Р. 5553. doi: 10.3390/CANCERS13215553

[89] Shibata M, Ishikawa A, Ishii J, et al. Stiffness of tongue squamous cell carcinoma measured using strain elastography correlates with the amount of collagen fibers in the tumor. Oral Radiol. 2022;38(2):278–287. doi: 10.1007/S11282-021-00556-0

[90] Shibata M., Ishikawa A., Ishii J., et al. Stiffness of tongue squamous cell carcinoma measured using strain elastography correlates with the amount of collagen fibers in the tumor // Oral Radiol. 2022. Vol. 38, N. 2. P. 278–287. doi: 10.1007/S11282-021-00556-0

[91] Riegler J, Labyed Y, Rosenzweig S, et al. Tumor elastography and its association with collagen and the tumor microenvironment. Clin Cancer Res. 2018;24(18):4455–4467. doi: 10.1158/1078-0432.CCR-17-3262

[92] Riegler J., Labyed Y., Rosenzweig S., et al. Tumor elastography and its association with collagen and the tumor microenvironment // Clin Cancer Res. 2018. Vol. 24, N. 18. P. 4455–4467. doi: 10.1158/1078-0432.CCR-17-3262

[93] Fan Y, Choi TH, Chung JH, et al. Hyaluronic acid-cross-linked filler stimulates collagen type 1 and elastic fiber synthesis in skin through the TGF-β/Smad signaling pathway in a nude mouse model. J Plast Reconstr Aesthet Surg. 2019;72(8):1355–1362. doi: 10.1016/J.BJPS.2019.03.032

[94] Fan Y., Choi T.H., Chung J.H., et al. Hyaluronic acid-cross-linked filler stimulates collagen type 1 and elastic fiber synthesis in skin through the TGF-β/Smad signaling pathway in a nude mouse model // J Plast Reconstr Aesthet Surg. 2019. Vol. 72, N. 8. P. 1355–1362. doi: 10.1016/J.BJPS.2019.03.032

[95] Varì S, Minoretti P, Emanuele E. Human dermal fibroblast response to hyaluronic acid-based injectable dermal fillers: an in vitro study. Postepy Dermatol Alergol. 2022;39(6):1088–1092. doi: 10.5114/ADA.2022.114927

[96] Varì S., Minoretti P., Emanuele E. Human dermal fibroblast response to hyaluronic acid-based injectable dermal fillers: an in vitro study // Postepy Dermatol Alergol. 2022. Vol. 39, N. 6. P. 1088–1092. DOI: 10.5114/ADA.2022.114927

[97] Mikhailova NP, Shekhter AB. Comparative study of interaction between modified and unmodified hyaluronic acid inject gels with human tissue. Journal of Aesthetic Medicine. 2014;13(3–4):55–62. (In Russ.)

[98] Михайлова Н.П., Шехтер А.Б. Сравнительное исследование взаимодействия инъекцированных гелей немодифицированной и модифицированной гиалуроновой кислоты с биотканью // Вестник эстетической медицины. 2014. Т. 13, № 3–4. С. 55–62.

[99] Galeeva AG, Kapuler OM, Saptarova LM, et al. Influence of interde rmal injection of a high-molecular hyaluronan on the level of some growth factors. Bashkortostan Medical Journal. 2017;12(4(70):56–59. EDN: ZULLCF

[100] Галеева А.Г., Капулер О.М., Саптарова Л.М., и др. Влияние интердермального введения препарата высокомолекулярного гиалуронана на уровне некоторых факторов роста // Медицинский вестник Башкортостана. 2017. Т. 12, № 4(70). С. 56–59. EDN: ZULLCF

[101] Zhu Y, Hu J, Yu T, et al. High molecular weight hyaluronic acid inhibits fibrosis of endometrium. Med Sci Monit. 2016;22:3438–3445. doi: 10.12659/msm.896028

[102] Zhu Y., Hu J., Yu T., et al. High molecular weight hyaluronic acid inhibits fibrosis of endometrium // Med Sci Monit. 2016. Vol. 22. P. 3438–3445. doi: 10.12659/msm.896028

[103] Itkonen Freitas AM, Mikkola TS, Rahkola-Soisalo P, et al. Quality of life and sexual function after TVT surgery versus Bulkamid injection for primary stress urinary incontinence: 1 year results from a randomized clinical trial. Int Urogynecol J. 2021;32(3):595–601. doi: 10.1007/S00192-020-04618-5

[104] Itkonen Freitas A.M., Mikkola T.S., Rahkola-Soisalo P., et al. Quality of life and sexual function after TVT surgery versus Bulkamid injection for primary stress urinary incontinence: 1 year results from a randomized clinical trial // Int Urogynecol J. 2021. Vol. 32, N. 3. P. 595–601. doi: 10.1007/S00192-020-04618-5

[105] Araklitis G, Baines G, Da Silva AS, et al. Healthcare professional’s choice for surgical management of stress urinary incontinence in a U.K. tertiary hospital. Eur J Obstet Gynecol Reprod Biol. 2021;263:7–14. doi: 10.1016/J.EJOGRB.2021.05.039

[106] Araklitis G., Baines G., Da Silva A.S., et al. Healthcare professional’s choice for surgical management of stress urinary incontinence in a U.K. tertiary hospital // Eur J Obstet Gynecol Reprod Biol. 2021. Vol. 263. P. 7–14. doi: 10.1016/J.EJOGRB.2021.05.039

[107] Li H, Westney OL. Injection of Urethral Bulking Agents. Urol Clin North Am. 2019;46(1):1–15. doi: 10.1016/j.ucl.2018.08.012

[108] Li H., Westney O.L. Injection of Urethral Bulking Agents // Urol Clin North Am. 2019. Vol. 46, N. 1. P. 1–15. doi: 10.1016/j.ucl.2018.08.012

RIGHTS & PERMISSIONS

Eсо-Vector